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Organelle-specific nanocarriers (NCs) are highly sought after for
delivering therapeutic agents into the cell nucleus. This necessi-
tates nucleocytoplasmic transport (NCT) to bypass nuclear pore
complexes (NPCs). However, little is known as to how comparably
large NCs infiltrate this vital intracellular barrier to enter the
nuclear interior. Here, we developed nuclear localization signal
(NLS)-conjugated polymersome nanocarriers (NLS-NCs) and studied
the NCT mechanism underlying their selective nuclear uptake.
Detailed chemical, biophysical, and cellular analyses show that
karyopherin receptors are required to authenticate, bind, and
escort NLS-NCs through NPCs while Ran guanosine triphosphate
(RanGTP) promotes their release from NPCs into the nuclear
interior. Ultrastructural analysis by regressive staining transmission
electron microscopy further resolves the NLS-NCs on transit in NPCs
and inside the nucleus. By elucidating their ability to utilize NCT,
these findings demonstrate the efficacy of polymersomes to
deliver encapsulated payloads directly into cell nuclei.
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nucleocytoplasmic transport
Nucleocytoplasmic transport (NCT) describes the exchangeof molecular cargoes across the nuclear envelope (NE) that
encloses the nucleus from the cytoplasm in eukaryotic cells (1, 2).
This is mediated by ∼60-nm-diameter channels in the NE known
as nuclear pore complexes (NPCs) (3), which form the sole
aqueous gateways to the genome (4). NPCs are permeable to
small molecules less than 40 kDa (or ∼5 nm), but the entry of
large nonspecific entities is impaired (5, 6). This selective barrier
functionality is attributed to several highly dynamic, intrinsically
disordered proteins known as phenylalanine–glycine nucleoporins
(FG Nups) that are located within the NPC central channel (7).
Exclusive NPC access is reserved for soluble transport receptors
known as karyopherins (or Kaps) (8) that usher biochemically
specific cargoes bearing nuclear localization signals (NLSs) into
the nucleus. To traverse the NPC barrier, Kaps such as the clas-
sical import receptor Kapβ1 (importinß1) exert multivalent bind-
ing interactions with the FG Nups (9). Meanwhile, Kapβ1 forms a
heterodimer (10) with an adaptor Kapα (Kapα•Kapβ1), which
authenticates and binds to NLSs. To complete nuclear import,
NLS-cargoes that transit in NPCs have to be released into the
nucleus. This is orchestrated by the small GTPase Ran (11), which
binds Kapβ1 in its GTP-bound form (RanGTP) to concomitantly
release Kapα and NLS-cargoes inside the nucleus.
In housing the genome, the nuclear interior constitutes a prin-
cipal target for applications such as chemotherapy (12) and gene
therapy (13). This has motivated efforts to engineer synthetic
nonviral delivery systems (vectors), which are highly sought-after
based on their tunable payload capacities, reduced pathogenicity,
and low immunogenicity (14). Nevertheless, it remains challenging
to engineer organelle-specific, nuclear-targeting nanoparticles that
shuttle therapeutic payloads directly into the nucleus (15). Key
challenges include biocompatibility, biological stability, degradation,
encapsulation efficiency, detection, and targeting accuracy (16).
Successful entry into the nuclear interior requires passage
through the intracellular barrier presented by NPCs. This can be
achieved by conjugating the simian virus 40 (SV40) large T antigen
monopartite NLS (17), the bipartite NLS from nucleoplasmin (18), or
the HIV-1 transactivating protein (TAT) peptide (19) to synthetic
entities. These include 39-nm-diameter gold nanoparticles (20),
50-nm-diameter silica nanoparticles (21), 60-nm-diameter magnetite
nanoparticles (22), 25-nm- and 150-nm-diameter chitosan nano-
particles (23), and 234-nm-diameter polymeric nanoparticles (24).
Still, several aspects of nuclear targeting are unresolved (16).
As a case in point, it is confounding how nanoparticles (23–25)
whose sizes exceed the maximum pore diameter are able to traverse
the NPC. Thus, it remains poorly understood how synthetic
entities bypass the selective NPC barrier and are taken up into
the nucleus.
Here, we have undertaken detailed biophysical, ultrastructural,
and cellular studies to resolve the nuclear targeting mechanism of
NLS-conjugated polymer vesicles, also called polymersomes (26).
These are sought after for diagnostic and therapeutic applications
(27–29) given their ability to function as molecular nanocarriers
(NCs) that encapsulate diverse hydrophilic and hydrophobic en-
tities within their aqueous lumens and membranes, respectively.
Based on their biocompatibility, superior structural stability over
liposomes (30), and ease of surface modifications for biological
specificity, our results underscore the role of NLS-conjugated
polymersome NCs as promising candidates for nuclear targeting
applications.
Significance
Synthetic nanomaterials are being sought to shuttle thera-
peutic payloads directly into the cell nucleus as a major target
for chemo- and gene-based therapies. However, it remains
uncertain whether and how synthetic entities are able to by-
pass the nuclear pore complexes (NPCs) that regulate transport
into and out of the nucleus. We have constructed biocom-
patible polymer vesicles that infiltrate NPCs and resolved
their nuclear uptake mechanism in vitro and in vivo. Their
ability to deliver payloads directly into cell nuclei is further
validated by transmission electron microscopy.
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Results
NC Design and Characterization. Polymersomes self-assembled
from poly(2-methyl-2-oxazoline)-block-poly-(dimethylsiloxane)-
block-poly(2-methyl-2-oxazoline) (PMOXA-PDMS-PMOXA)
triblock copolymers are known to exhibit low toxicity in vitro and
in vivo (31, 32), and did not provoke an innate immune re-
sponse in mice following intraperitoneal injection (33). Here,
we synthesized two variants: PMOXA4-PDMS44-PMOXA4 (Mn =
4,000 Da) and a maleimide-terminated derivative Mal-PMOXA4-
PDMS34-PMOXA4-Mal (Mn = 3,800 Da) that were obtained with
a molecular weight dispersity of 1.7 and 2.8, respectively (SI Ap-
pendix, Fig. S1). In this regard, polydispersity may be advantageous
for the formation of polymersomes leading to more uniform size
distributions (34). Both polymers are optimized for polymersome
self-assembly based on their average amphiphilic block-copolymer
ratio (35) (i.e., f, the hydrophilic molecular mass fraction in re-
lation to the total molecular mass) that was 29% and 32%, re-
spectively. Afterward, we conjugated the bipartite nucleoplasmin
NLS (18) (CWKRLVPQKQASVAKKKK; M = 2,127 Da) via a
catalyst free thiol-ene click reaction (SI Appendix, Fig. S2) to
render the maleimide-terminated NCs (henceforth NLS-NCs) vi-
able for NCT (Fig. 1). Additionally, non–NLS-conjugated NCs
were assembled from PMOXA4-PDMS44-PMOXA4 exclusively
(denoted as blank NCs) and used as nonspecific controls through-
out this study. For clarity, both NLS-NCs and blank NCs are col-
lectively referred to as NCs.
To facilitate nuclear uptake, we extruded NCs that were com-
patible with the size of the NPC channel. Cryoelectron microscopy
(cryo-EM) revealed spherical NLS-NCs and blank NCs compris-
ing hollow lumens enclosed by polymeric membranes that were
8.4 ± 1.1 and 8.2 ± 1.5 nm thick, respectively (Fig. 2A). Mean-
while, transmission electron microscopy (TEM) provided radial
distributions of 22 ± 13 and 25 ± 9 nm for NLS-NCs and blank
NCs (Fig. 2 B and C), respectively. This was consistent with dy-
namic light scattering (DLS) analysis, which reported hydrody-
namic radii (Rh) of 28 ± 13 and 29 ± 14 nm, and polydispersity
indices of 0.22 and 0.23 for NLS-NCs and blank NCs, respectively
(Fig. 2 C, Inset). Static light scattering (SLS) was also employed to
evaluate NC radius of gyration (Rg), structure, and mass. Knowing
both Rg and Rh allowed us to calculate a form factor, r = Rg/Rh,
which approached unity, thereby indicating that the NCs exhibited
a membrane-enclosed vesicular structure (36) (i.e., hollow
spheres) (SI Appendix, Fig. S3 and Table S1). Moreover, the su-
pramolecular NC mass was determined to be 88.3 ± 2.1 MDa,
which corresponds to 22,100 polymer chains per NC on average.
This equates to an approximate concentration of 23 nM for a
2 mg/mL stock solution for both blank NCs and NLS-NCs, re-
spectively. Because NLSs are not fluorescent, we could not di-
rectly measure the number of NLSs per NLS-NC. Instead, we
conjugated SAMSA fluorescein probes to maleimide-terminated
NCs to act as NLS surrogates. Thereafter, fluorescence correla-
tion spectroscopy gave an estimate of 27 ± 9 NLSs per NC (SI
Appendix, Fig. S4 and Table S2) bearing in mind that 1) maleimide
end groups hydrolyze over time and/or 2) SAMSA-NC binding
might reduce chromophore brightness. Following NLS conju-
gation, ζ-potential measurements yielded 18.7 ± 1.7 mV for NLS-
NCs and 25.5 ± 9.4 mV for blank NCs, respectively.
NCs were further evaluated by dual-color fluorescence life-
time cross-correlation spectroscopy (dcFLCCS) upon incorpo-
rating Bodipy630/650 dye (hereafter Bodipy) and Ruthenium Red
(λEx = 536 nm; hereafter RR) as model cargoes. Specifically, the
lipophilic Bodipy incorporates into the polymeric membrane,
whereas the hydrophilic RR is encapsulated within the aqueous
NC lumen (SI Appendix, Fig. S5 A and B). Indeed, dcFLCCS
confirmed their simultaneous incorporation and encapsulation
within NCs (Fig. 2D). This is evident from the large cross-
correlation (CC) amplitude and the pronounced shift of the au-
tocorrelation (AC) curves toward longer diffusion times in com-
parison to freely diffusing RR (Fig. 2 D, Inset) or Bodipy (SI
Appendix, Fig. S5C). Fitting the RR AC curve to SI Appendix, Eq.
S3.1 gave a diffusion coefficient D = 6.5 ± 0.7 μm2/s that corre-
sponds to Rh = 35.5 ± 1.0 nm by invoking the Stokes–Einstein
equation. Likewise, we obtained D = 6.7 ± 0.2 μm2/s and Rh =
35.0 ± 0.8 nm from the Bodipy AC curve. The fraction of NCs
with coexisting RR and Bodipy obtained from the cross-correlation
is 39% for NLS-NCs and 30% for blank NCs (SI Appendix,
Fig. S5D).
Kapα•Kapβ1 Binding to NLS-NCs. Next, we used dcFLCCS to
quantify the equilibrium binding affinity of Kapα•Kapβ1 to the
NLS-NCs (37) (SI Appendix). Bodipy-only NLS-NCs (without
RR) were titrated in the range of 25 to 590 pM against a constant
concentration of 200 nM Kapα, 18 nM unlabeled Kapβ1, and
2 nM Atto-550-labeled Kapβ1. Labeled Kapβ1 was required to
facilitate dcFLCCS measurements. Here, the CC amplitude be-
tween Kapα•Kapβ1 and NLS-NCs increased with NLS-NC
concentration ðCNLS−NCÞ as the increased availability of NLS bind-
ing sites shifts the equilibrium toward NLS-NC bound Kapα•Kapβ1
(Kapα•Kapβ1•NLS-NC; Fig. 3A). The corresponding relative
CC amplitude (38) (SI Appendix, Eq. S6.1) allows to calculate
the binding curve of Kapα•Kapβ1•NLS-NC formation (black squares
in Fig. 3B). Fitting the binding curve to a multiple independent
binding site model (SI Appendix, Eq. S6.2) yields a maximum of
57 ± 3 Kapα•Kapβ1 copies per NLS-NC at saturation (>345 pM),
which is consistent with the estimated number of NLSs per NC.
This also gives an apparent binding affinity KD ≤ 0.4 nM for
Kapα•Kapβ1-NLS binding (SI Appendix, Eq. S6.2) that is com-
parable to literature values (39).
Fig. 1. Organelle-specific targeting of polymersome NCs into the cell nu-
cleus. (A) NLS-NCs self-assemble from amphiphilic PMOXA-PDMS-PMOXA
triblock copolymers. Two model compounds are used to test for nuclear
delivery: Ruthenium Red (RR) that is encapsulated within the NLS-NC lumen,
and Bodipy 630/650 that incorporates into its polymeric membrane. (B) The
nuclear transport mechanism involves Kapα•Kapβ1 that 1) authenticates
NLS-NCs for selective NPC transport, 2) binds to FG Nups, and 3) releases NLS-
NCs into the nucleus upon binding RanGTP.
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Upon binding to NLS-NCs, free Kapα•Kapβ1 complexes in
solution are depleted and their concentration ðCfreeKapα=β1Þ decreases
with an increase in NLS binding sites (blue circles in Fig. 3B).
Based on fitting parameters from SI Appendix, Eq. S6.2, this re-
duction can be accurately simulated as a function of the total NLS
concentration CNLS (blue line in Fig. 3B and SI Appendix, Eqs.
S6.3–S6.6).
Meanwhile, free Atto-550 did not interact with the NLS-NCs,
thereby indicating that Kapα•Kapβ1 bound NLS-NCs specifically
(SI Appendix, Fig. S6). Moreover, it is evident from the lack of
cross-correlation (Fig. 3C) that Kapα•Kapβ1 did not interact
with blank NCs.
Kapα•Kapβ1 Mediates NLS-NC–FG Nup Interactions. Multivalent
interactions between Kaps and FG Nups facilitate selective
transport across the NPC (40). We ascertained the binding of
Kapα•Kapβ1•NLS-NCs to three FG Nups (cNup98, cNup214,
and cNup153) by surface plasmon resonance (SPR) (SI Appendix,
Fig. S7) (9). Langmuir isotherm analysis (Fig. 4) indicates that the
apparent binding affinity (KD) of Kapα•Kapβ1•NLS-NCs to
cNup153 (and also cNup214 and cNup98) does not differ from
that of standalone Kapα•Kapβ1, being 18.4 ± 9.0 and 24.8 ±
1.7 nM, respectively. This is likely due to a fraction of free
Kapα•Kapβ1 that is generally present with Kapα•Kapβ1•NLS-
NCs at equilibrium. Regardless, their binding to the FG Nups
provoked a maximal binding response (in resonance units [RU])
that was ∼2 kRU higher than standalone Kapα•Kapβ1. This
correlates to an increase of bound mass, which can be calculated
from the relation 1,300 RU = 1 ng/mm2 (41) to give 1.5 ng/mm2 or
∼9 NLS-NCs per μm2.
As controls, blank NCs mixed with Kapα•Kapβ1 elicited a
similar binding response to standalone Kapα•Kapβ1 in terms of
its magnitude, which signified a lack of NC binding to the FG
Nups (SI Appendix, Fig. S7 A–C). Also, neither blank NCs nor
NLS-NCs showed FG Nup binding in the absence of Kapα•Kapβ1
(SI Appendix, Fig. S7D). This verifies that Kapα•Kapβ1 mediates
the selective binding of the NLS-NCs to the FG Nups as a pre-
requisite to bypass the NPC selective barrier (SI Appendix,
Table S3).
RanGTP Regulates NLS-NC Nuclear Uptake in Permeabilized Cells.
During import, RanGTP binds to Kapβ1 to trigger the release
of Kapα and its cargoes in the nucleus (10, 11). To evaluate this,
we employed a permeabilized cell assay using a so-called “Ran
mix” (40) that includes RanGDP, key transport factors, and an
energy-regenerating system that reactivates an enzyme known as
Ran guanine nucleotide exchange factor (or RanGEF) that
converts RanGDP to RanGTP in the nucleus. In doing so, we
sought to ascertain whether RanGTP promoted NLS-NC nu-
clear uptake. This was carried out by varying the amount of
RanGDP in Ran mix from 0 to 5 and 20 μM whilst keeping the
NLS-NC concentration constant. Negligible amounts of Bodipy-
labeled NLS-NCs were detected in the nucleus after a 2-h in-
cubation when RanGTP was absent (Fig. 5A). However, near
physiological concentrations (42), 5 μM RanGTP was sufficient
to drive nuclear NLS-NC uptake, whereas 20 μM RanGTP en-
hanced it (Fig. 5B). Meanwhile, the signal of Atto550-labeled
Kapβ1 at the nuclear envelope indicated the presence of
Kapα•Kapβ1 or Kapα•Kapβ1•NLS-NCs on transit at the NPCs
in all three cases. In other words, Kapα•Kapβ1 is necessary but
insufficient for the nuclear uptake of NLS-NCs. In marked
contrast, blank NCs did not pass through NPCs in the presence
of Ran mix (SI Appendix, Fig. S8). Hence, NLS-NCs require
Kaps to enter NPCs, whereas nuclear uptake requires RanGTP
to bind Kapβ1 and release Kapα and the NLS-NCs from the
NPCs (40).
Resolving NLS-NCs That Infiltrate the Nucleus in Live Cells. Next, we
studied the nuclear uptake of Bodipy-NLS-NCs and Nile Red
(NR)-labeled blank NCs into live HeLa cells by time-lapse fluo-
rescence microscopy (Fig. 6 A and B). PMOXA-PDMS-PMOXA
NCs enter cells through an endosomal escape pathway (31).
Subsequently, NLS-NC uptake into the nucleus doubled after 12 h
and was consistently more pronounced than blank NCs (Fig. 6C).
In contrast, blank NCs were predominant in the cytoplasm and
along the nuclear envelope (Fig. 6A). Such differences are further
evident by comparing between their respective nuclear and cyto-
plasmic signals as time progresses. Whereas blank NCs plateau at
similar relative intensities in both compartments within 12 h, NLS-
NCs continue to accumulate in the nucleus but not in the cyto-
plasm (SI Appendix, Fig. S9). Still, neither NLS-NCs nor blank
Fig. 2. Polymersome NC characterization. (A) Cryo-EM resolves the spherical shape and hollow interior of NLS-NCs (Left) and blank NCs (Right). (Scale bar: 50
nm.) Corresponding zoom-ins show the membrane thickness of individual NCs (*). (Scale bar: 20 nm.) (B) TEM micrographs enable general size analysis of NLS-
NCs (Left) and blank NCs (Right). (Scale bar: 100 nm.) (C) Size distribution of NLS-NCs and blank NCs as determined by TEM and verified by DLS (Inset). (D) Dual-
color fluorescence lifetime cross-correlation spectroscopy (dcFLCCS) (black) verifies RR encapsulation (red) inside the NLS-NC lumen and Bodipy insertion inside
its membrane (blue), respectively. (Inset) Comparison of free and encapsulated RR.
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NCs were toxic to the HeLa cells up to 48 h (Fig. 6D). Indeed,
differences in the nuclear uptake behavior of NLS-NCs and
blank NCs are evident following coincubation in the same cells
(Fig. 6B).
TEM ultrastructural analysis was then used to verify whether
individual NLS-NCs did indeed translocate through NPCs and if
they retained their structure following NCT. Unlike inorganic
nanoparticles, however, it is formidable to resolve the polymeric
NCs in the crowded cellular environment due to their low image
contrast. We therefore reasoned that an EDTA regressive staining
protocol (43) could chelate and deplete uranyl stained material
(e.g., chromatin) so as to enhance the visibility of the NCs (Ma-
terials and Methods). This revealed features that bore the distinct
circular imprints of NLS-NCs (Fig. 6E) and blank NCs (SI Ap-
pendix, Fig. S10), respectively. Overall, we found that 30%, 25%,
and 45% NLS-NCs were localized in the cytoplasm, at NPCs, and
within the nuclear interior, respectively (Fig. 6F). Their localiza-
tion was irrespective of NLS-NC size, which is 69 ± 12 nm in di-
ameter (n = 292; SI Appendix, Fig. S10). In comparison, a 77%
majority of blank NCs measuring 69 ± 14 nm in diameter (n =
166) were found in the cytoplasm, which indicates that their lo-
calization was size independent. Thus, a majority of blank NCs was
prevented from entering the nucleus despite being comparable in
size to the NLS-NCs, as well as NPCs that were 61 ± 16 nm wide
(n = 197; SI Appendix, Fig. S10).
Discussion
In this work, we have developed polymersome NCs and mapped
their transport pathway into the cell nucleus at the molecular,
ultrastructural, and cellular levels. Our findings show that NLS-
NCs emulate authentic cargo specificity to bypass NPCs and enter
into the cell nucleus. Moreover, they are biocompatible, have low
cytotoxicity (28), and possess a superior structural integrity that is
compliant to changes in shape without rupturing (44). Crucially,
NLS-NCs harbor aqueous lumens that are amenable to the en-
capsulation of various molecular payloads as a prerequisite. This is
important for delivering nuclear specific drug compounds (12),
protein-based therapeutics (16), and plasmids in gene-based
therapies (45). Moreover, their ∼8-nm-thick polymer mem-
branes may offer enhanced stability in cellular environments or
when binding to proteins (e.g., Kapα•Kapβ1) in comparison to
liposomes (46). Not least, the relative ease of conjugating different
peptides to these polymersomes by thiol-ene “click” reactions
makes them attractive as candidates for diverse applications in
nanomedicine.
We have further shown that: 1) Kapα•Kapβ1 authenticates
and binds NLS-NCs; 2) the presence of multiple Kapα•Kapβ1
copies per NLS-NC ensures its binding to the FG Nups, but may
further facilitate efficient transport through the NPC, as has
been suggested for large cargoes (47–49); and 3) RanGTP is
required to displace the NLS-NCs from NPCs into the nuclear
interior by binding Kapβ1. Indeed, NPCs exclude blank NCs in the
absence of the above molecular interactions.
This study includes a methodological advance to resolve indi-
vidual NCs in cells using a TEM-based ultrastructural analysis. Our
TEM results verify that NLS-NCs, but not blank NCs, can suc-
cessfully transit and traverse NPCs. This is unexpected, as the largest
TEM-resolved entities to reside in the NPC are 39-nm-diameter
gold nanoparticles (20) and 30- to 40-nm-diameter viral capsids (50,
51). Interestingly, interactions between Kapα•Kapβ1•NLS-NCs and
the FGNups might lead to a reduction of the NPC barrier (52), and/
or may alter pore shape (53). This might explain how NPCs
accommodate NLS-NCs despite bearing comparable diameters.
In addition, the NLS-NCs may deform (44) as they pass through
the pore, although the resolution of the current experiments
precludes such observations. Still, it is difficult to rationalize how
large NLS-conjugated nanoparticles (23–25) (between 143 and
234 nm in size) that significantly exceed the NPC diameter may
Fig. 3. Kapα•Kapβ1 binding to NLS-NCs. (A) The binding strength of
Kapα•Kapβ1 to NLS-NCs was assessed via dcFLCCS. Increasing concentrations
of NLS-NCs were titrated against 20 nM Kapβ1 and 200 nM Kapα. Signal
cross-correlation GCC(t) increases due to the increasing degree of binding. (B)
Binding curve fitting (black) obtained from the fraction of bound Kaps
(black squares) via the relative cross-correlation amplitude yields 57 ± 3
Kapα•Kapβ1 complexes per NLS-NC with KD ≤ 0.4 nM. The drop in free
Kapα•Kapβ1 concentration (blue circles) is accurately simulated (blue line)
based on the assumption that the maximum number of bound Kapα•Kapβ1
complexes per NLS-NC is equal to the number of competent NLS binding
sites. See SI Appendix, section 6 for details. (C) Blank NCs are not recognized
by Kapα•Kapβ1 complexes and show no signal cross-correlation (black).
Zelmer et al. PNAS | February 11, 2020 | vol. 117 | no. 6 | 2773
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traverse it. Hence, TEM-based ultrastructural analysis would be
essential to verify these reports, such as to ensure that degradation
did not occur prior to import (16). Regardless, our analysis shows
that the NLS-NCs are appropriately sized for traversing NPCs,
which sets a maximal design cutoff for future nuclear targeting
systems. Future efforts will reveal how adjusting NLS-NC size, the
degree of NLS functionalization, membrane thickness, etc., can
optimize nuclear uptake. Other challenges include achieving a
controlled release of NLS-NC payloads within the nucleus and
studying how cells might respond to degraded NLS-NC material.
Materials and Methods
Synthesis. See SI Appendix for details.
Polymersome Preparation. NLS-NCs were prepared via a solvent-free method.
Here, a homogeneous amphiphilic polymer film was deposited onto the
bottom of a round-necked flask. This consisted of 1.9mg of PMOXA4-PDMS44-
PMOXA4 (95 wt%) and 0.1 mg of PMOXA4-PDMS34-PMOXA4 (5 wt%) where
34% of all polymer end groups had been substituted with active maleimide
linking sites, i.e., Mal-PMOXA4-PDMS34-PMOXA4-Mal (SI Appendix). Hence,
at least 1.6% of each polymersome is composed of Mal-PMOXA4-PDMS34-
PMOXA4-Mal. Polymersome self-assembly followed film rehydration and
desorption in 1 mL of 75-μM RR in PBS. The heterogeneous polymersome
dispersion was extruded 15 times through a polycarbonate membrane of
50-nm pore size (Whatman Nuclepore Track Etch Membrane). Excess RR was
removed via size exclusion chromatography through a Sephadex G-25
column (GE Healthcare Life Science HiTrap Desalting Column). Cysteine-
terminated bipartite nuclear localization sequences from nucleoplasmin 2
(CWKRLVPQKQASVAKKKK; M = 2,127 Da; GenScript; Lot No. 91262870001/
PE3665) were then conjugated to the polymersome structure by a spontaneous
thiolene click reaction. After 12 h, excess cysteine was added to quench
unreacted maleimide sites in an overnight reaction. Pure NLS-conjugated
polymersomes (NLS-NCs) were obtained by dialyzing out free NLS and free
cysteine against PBS using dialysis tubing with a molecular mass cutoff
of 3.5 kDa in 2-h triplicates. When required, NLS-NCs were also labeled
with 200 nM lipophilic Bodipy 630/650 or 1 μM lipophilic Nile red 552/636,
respectively. Negative control blank polymersome NCs (blank NCs) were
prepared from 2 mg of PMOXA4-PDMS44-PMOXA4 exclusively using the
same preparation and purification procedures. Depending on the experiment,
blank NCs were also labeled with 1 μM lipophilic Nile red 552/636.
Protein Expression, Purification, and Labeling. Cysteine-tagged FG domains of
human Nup214, Nup98, and Nup153 were cloned, expressed, and purified as
described (9). Kapα, Kapβ1, and RanGDP were also expressed and purified as
described (40). Kapβ1 labeling by Atto-550 succinimidyl ester (Atto-550 NHS-
ester or simply Atto-550) was carried out in PBS buffer using a standard
procedure (Invitrogen). Conjugation efficiency was determined by spectro-
photometry (Nanodrop 2000).
Cryo-EM. Four microliters of 2 mg/mL polymersome dispersions were dropped
onto glow discharged carbon-coated lacey copper grids (300 mesh; Electron
Fig. 4. Kapα•Kapβ1 mediates NLS-NC binding to the FG Nups. (A) Kapα•Kapβ1•NLS-NCs elicit the highest FG Nup- binding response as measured by SPR. (B)
Blank NCs do not bind the FG Nups in the presence of Kapα•Kapβ1. (C) When NCs are absent, the binding response of standalone Kapα•Kapβ1 is similar to B.
This indicates that the large binding response of Kapα•Kapβ1•NLS-NCs results from the added mass of each NLS-NC. Langmuir isotherm fits (solid lines where
a, b, and c correspond to A, B, and C, respectively) yield the maximal response signal (Rmax; filled circles) and the equilibrium dissociation constants (KD; open
circles) shown in the Insets and summarized in SI Appendix, Table S3.
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Microscopy Science). Samples were blotted in a commercial vitrification
system (Vitrobot Mark IV; Thermo Fisher) and after plunge freezing the grids
were transferred at −178 °C into a Gatan 626 cryoholder (Gatan) and imaged
in a Tecnai F20 microscope (Thermo Fisher) operated at 200 kV. Resulting
cryo-EM images were recorded with a BM-Ceta camera (4,096 × 4,096 pixels;
Thermo Fisher).
TEM. Samples were imaged on a Philips CM100 microscope operating at 100-
kV acceleration voltage and equipped with a charge-coupled device (CCD)
camera. Dilute NC solutions (5 μL of 0.2 mg/mL polymersomes) were de-
posited onto prehydrophilized carbon-coated 400 mesh copper grids and
negatively stained with 2% uranyl acetate solution. Size analysis was carried
out using ImageJ (54), taking at least 150 individual NC specimens for
evaluation. Diameters were calculated by taking the average between the
minor and major axes of each individual NC.
Dynamic and Static Light Scattering.DLS and SLS experiments were performed
on a commercial goniometer (LS Instruments) equipped with a 30-mW HeNe
laser (wavelength, 633 nm) and two parallel avalanche photomultiplier de-
tectors (APDs). The detected count rate was set to 40 kHz via an automatic
laser intensity regulation function. After-pulsing effects were antagonized by
pseudo–cross-correlation between the signals detected in the two APDs. The
scattering intensity of freshly extruded polymersomes was measured in dust-
free 10-mm high-precision quartz cells, which were placed in an optically
matching thermostat vat at 298 K.
ζ Potential. All measurements were performed on a Zetasizer Nano ZSP
(Malvern Instruments) at 298 K. NLS-NC and blank NC dispersions of 0.5 mg/mL
were diluted 20-fold in Millipore water to 25 μg/mL and <10 mM salt
concentration. Each sample was measured in triplicate to determine the
average ζ potential.
Dual-Color Fluorescence Lifetime Cross-Correlation Spectroscopy. Mea-
surements were performed on an Olympus IX73 inverted microscope stand
equipped with a 1.2 N.A. water-immersion 60× superapochromat objective
(UplanSApo; Olympus) and suitable emission and excitation bandpass filters
(Semrock and AHF). Two pulsed diode lasers (LDH-P-FA-530 and LDH-D-C-
640; PicoQuant) were operated at 40 MHz for pulse interleaved excitation
dcFLCCS (Sepia II; PicoQuant). Emitted photons were detected in two sepa-
rated channels coupled with two SPAD detectors (SPCM CD3516H; Excelitas)
and a time-correlated single-photon counting unit to generate picosecond
histograms also called lifetime spectra (16-ps resolution; HydraHarp 400)
from the statistical photon arrival times. The laser powers were set to 20 μW
for the LDH-P-FA-530 and to 17 μW for the LDH-D-C-640 laser and the in-
tensity fluctuation recorded for 120 s with a correlation integration time
taken as 2 s. The confocal volume was calibrated using free dyes of known
diffusion constants D (using Rhodamine B in excitation channel 530 with D =
426.4 μm2/s at 298 K and a structural parameter of S = 4, and Atto-655NHS
ester in excitation channel 640 with D = 403.6 μm2/s at 298 K and a structural
parameter of S = 4). All measurements were performed 20 μm away from
the coverslip.
SPR. SPR binding assays were performed using a BiacoreT200 (GE Healthcare)
at 25 °C using four flow cells as described previously (9, 41). See SI Appendix
for details.
Cell Culture. HeLa cells were cultured in Dulbecco’s modified Eagle medium
GlutaMAX-I (DMEM) (Gibco Life Sciences) and supplemented with 10% (vol/vol)
Fig. 5. NLS-NCs depend on RanGTP for nuclear uptake in permeabilized cells. (A) NLS-NC nuclear import is highest in 20 μM RanGTP and lowest when
RanGTP is absent. (Scale bar: 10 μm.) (B) Time-lapse imaging indicates that the nuclear import rates of NLS-NCs increase with RanGTP concentration.
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Fig. 6. Nuclear uptake and ultrastructural analysis of NLS-NCs in HeLa cells. (A) Fluorescence imaging shows that NLS-NCs import into the nuclei of live
cells, whereas blank NCs are largely rejected. (Scale bar: 10 μm.) (B) This is most striking when both NLS-NCs and blank NCs are coincubated in the same
cells. (Scale bar: 10 μm.) (C ) Time-lapse imaging over 12 h reveals that nuclear import rate is enhanced for NLS-NCs in comparison to the passive diffusion
of blank NCs. (D) NLS-NC and blank NC-treated HeLa cells remain viable after 48 h. (E ) TEM ultrastructural analysis resolves NLS-NCs (black arrows) that
traverse NPCs to enter the cell nucleus. c, cytoplasm; n, nucleus. (Scale bar: 200 nm.) (F ) Statistical distribution of NLS-NCs (n = 292 in 56 cells) in com-
parison to blank NCs (n = 166 in 21 cells; SI Appendix, Fig. S10).
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FBS (BioConcept), 100 units/mL penicillin, and 100 μg/mL streptomycin (Sigma-
Aldrich). Cells were maintained at 37 °C and 5% CO2.
Permeabilized Cell Assays. HeLa cells were cultured in eight-well glass bottom
μ-slides (ibidi) up to 80% confluency in DMEM mixed with 10% (vol/vol) FBS.
The cells were washed three times with PBS before permeabilization in
digitonin solution (40 μg/mL in transport buffer) for 5 min (40). This was
followed by a triple wash in PBS buffer, followed by nuclear staining with
DAPI (Sigma-Aldrich), and another triple wash with PBS. Excess buffer was
wicked off and the permeabilized cells incubated with 300 μL of Ran mix for
30 min (containing 1 μM Kapβ1; 2 μM Kapα; 5 μM, 20 μM, or no RanGDP;
1 mM GTP [Roche]; 1 μM NTF2; 100 μM ATP [Roche]; 4 mM creatine phos-
phate [Roche]; 20 U/mL creatine kinase [Roche]). Thirty microliters of either
6 nM Bodipy 630/650-labeled NLS-NCs or 6 nM Nile Red 552/636-labeled
blank NCs were added to the Ran mix solution in order to obtain a final NC
concentration of 0.6 nM. A DeltaVision wide-field fluorescence microscope
was used for time-lapse measurements over 120 min with images taken
every 10 min. Studies on permeabilized cells were repeated three times at
each experimental condition.
Live-Cell Imaging. Nuclear uptake into HeLa cells was studied via wide-field
fluorescence microscopy. Cultured cells were seeded in eight-well glass
bottom μ-slides (ibidi) using DMEM with 10% (vol/vol) FBS as nutrition me-
dium and grown until they reached a confluency of 50 to 80%. In all live-cell
studies, we stained the cell nuclei with Hoechst (Thermo Fisher) and used
DMEM without phenol red (Gibco). To begin with the experimental assay, a
concentration of 0.6 nM Bodipy 630/650-labeled NLS-NCs or 0.6 nM Nile Red
552/636-labeled blank NCs were added to the cell medium. The cells were
then transferred to an Olympus IX71 stand that was preheated to 37 °C with
a 5% CO2 atmosphere. A DeltaVision core wide-field fluorescence micro-
scope was equipped with a Photometrics CoolSNAP HQ2 camera coupled to
an interline CCD transfer and was operated via SoftWorx 4.12 software. A
60× oil objective was applied for imaging. Relative nuclear fluorescence
intensities were determined via signal colocalization with the chromatin
stain Hoechst. NC uptake kinetics was followed over 12 h with time-lapse
images taken every 30 min for the first 3 h, followed by images being
recorded every 1 h for the next 9 h. Cell studies were repeated three times at
each experimental condition.
Fluorescence Image Analysis. NC uptake in both permeabilized HeLa cells and
live HeLa cells was analyzed by three-dimensional (3D) deconvolution fluo-
rescence microscopy. Pixel saturation due to the cellular accumulation of NCs
throughout the experimental time course was avoided by determining the
optimal exposure prior to image acquisition. Datasets were recorded over a
Z-stack range of 15 μm at 0.35-μm z intervals at each time point. These were
analyzed using Imaris software with an integrated ImarisCell module based
on the fluorescence intensities of Bodipy 630/650-labeled NLS-NCs and Nile
Red 552/636-labeled blank NCs, respectively. Each signal was summed over
the entire 3D cell volume at each time point. Nuclear uptake was determined
from the signals that colocalized with chromatin staining by Hoechst in the
same 3D volume. Fluorescence intensities in the cytoplasm were obtained by
subtracting the nuclear intensities from the sum intensity over the entire cell
volume (SI Appendix, Fig. S9). Relative fluorescence intensities at each time
point were calculated by normalizing the average detected photon count per
unit volume by its corresponding value at time equals zero (i.e., at the start of
the experiment). This analysis was applied to a total of 28 cells incubated with
NLS-NCs and 18 cells incubated with blank NCs.
Cell Viability. Cell viability was determined using a CellTiter 96 AQueous One
Solution Cell Proliferation Assay (MTS; Invitrogen) based on a standard
protocol. HeLa cells were seeded in a 96-well plate (5,000 cells per well). After
24 h, cells were dosed with increasing concentrations of blank NCs or NLS-NCs
(0.16, 0.35, and 0.65 mg/mL, final concentrations) and incubated further for
48 h. The MTS reagent (20 μL) was added to each well and after 2-h ab-
sorbance at 490 nm was measured using a Spectramax plate reader. Back-
ground absorbance was subtracted from each well, and data were normalized
to control untreated cells. Experiments were done in quadruplicate (n = 4),
and data were plotted using Origin (OriginLab).
Ultrastructural Analysis. HeLa cells were seeded in 100 × 21-mm cell culture
dishes (Thermo Fisher) and grown in DMEM media (Gibco) containing 10%
(vol/vol) FBS. The cells were then incubated for 12 h at 37 °C in 5% CO2 with
0.6 nM RR-NLS-NCs or 0.6 nM RR-blank NCs, respectively. Thereafter, the cells
were washed with PBS three times and collected into cell pellets that were
immediately frozen with Karnovsky fixative and embedded in Epon resin.
Ultrathin 50-nm sections were cut and mounted onto nickel grids and
treated according to a regressive EDTA staining protocol (43). To do so, the
thin sections were floated over a 6%age aqueous uranyl acetate solution for
a reaction time of 5 min. Subsequent rinsing with double distilled H2Odd
followed a second floating step on a 0.2 M EDTA/water solution. The pH of
the solution was raised to 7.0 by adding 1 N sodium hydroxide drop by drop
over a 30-min time course. The sections were rinsed again with H2Odd and
stained with lead citrate for 5 min before rinsing them another time with
H2Odd. The samples were imaged on a Philips CM100 transmission electron
microscope operated at 100-kV acceleration voltage and equipped with a
CCD camera. Subsequent statistical and size distribution analysis was carried
out in ImageJ (54).
Data Availability. All data are included in the paper and SI Appendix.
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